A carregar...

Retrospective study of adjuvant icotinib in postoperative lung cancer patients harboring epidermal growth factor receptor mutations

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations occur in about 50% of Asian patients with non‐small cell lung cancer (NSCLC). Patients with advanced NSCLC and EGFR mutations derive clinical benefit from treatment with EGFR‐tyrosine kinase inhibitors (TKIs). This study assessed the effi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Yao, Shuyang, Zhi, Xiuyi, Wang, Ruotian, Qian, Kun, Hu, Mu, Zhang, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5130296/
https://ncbi.nlm.nih.gov/pubmed/27766784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12365
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!